impactCancer Spring 2017
With the recent conclusion of But for Ohio State—the most successful fundraising campaign in Ohio State’s 146-year history—we have taken another giant step toward creating a cancer-free world.
The campaign, which began in 2009 and ended in September 2016, surpassed its goal of $2.5 billion by raising more than $3 billion from over 750,000 donors. Some $420.8 million of the monetary total was generated by our Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James).
That’s a huge contribution to a campaign that Ohio State University President Michael V. Drake, MD, called “historic,” noting that it will benefit our community and communities around the world for generations to come. The OSUCCC – James contribution is a tribute not only to those who spearheaded our efforts— including our superlative campaign medical director Ted Teknos, MD, and The James Foundation Board chaired by the tireless Lisa Hinson—but also to the generosity of our alumni and friends in the community who have stepped up to help us continue our important work.
Another recently completed effort designed to help us end cancer is Pelotonia 16, the eighth installment of an annual grassroots bicycle tour that draws riders and donors from around the world to raise money for cancer research at Ohio State. Pelotonia 16, held last Aug. 6-7, raised a record $24.1 million, boosting the overall total for this event to more than $130 million. Details are in this issue of impactCancer.
Also herein, you’ll find stories about: a new statewide initiative we launched in March through $3 million in Pelotonia funding that will help us take aim at lung cancer; the recent recruitment of Cheryl Taylore Lee, MD, a bladder cancer specialist who chairs the Department of Urology at Ohio State and whose work is also supported by Pelotonia dollars; profiles of grateful patients treated at the OSUCCC – James; and our 2016 Press Ganey Guardian of Excellence Award® for patient experience.
I believe the contents of this issue signify that we’re on the right track for someday conquering cancer. I hope that you will agree.
Michael A. Caligiuri, MD
Director, The Ohio State University Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute
President, American Association for Cancer Research